SCHEMBL7494872

SCHEMBL7494872

CCCCC(=O)NC1CCCCC1

nearest known ligand 0.86

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.74
HDAC3 O15379 2/20 0.62
HDAC1 Q13547 2/20 0.62
HDAC2 Q92769 2/20 0.62
HDAC10 Q969S8 2/20 0.62
HDAC11 Q96DB2 2/20 0.62
HDAC8 Q9BY41 2/20 0.62
HDAC6 Q9UBN7 2/20 0.62
NCOR2 Q9Y618 1/20 0.62
ALDH1A1 P00352 1/20 0.61
HPGD P15428 1/20 0.59
GNAI3 P08754 1/20 0.58
GNAO1 P09471 1/20 0.58
GNAI1 P63096 1/20 0.58
EPHX1 P07099 9/20 0.57
EPHX2 P34913 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23989211 1.00 SMN1; SMN2 (0.74) SMN1; SMN2HDAC3HDAC1HDAC2HDAC10
SCHEMBL4674083 0.98 SMN1; SMN2 (0.77) SMN1; SMN2HDAC3HDAC1HDAC2HDAC10
SCHEMBL22055472 0.94 SMN1; SMN2 (0.78) SMN1; SMN2HDAC3HDAC1HDAC2HDAC10
SCHEMBL931252 0.94 SMN1; SMN2 (0.78) SMN1; SMN2HDAC3HDAC1HDAC2HDAC10
Hexadecanoic Acid Cyclohexylamide SCHEMBL1456860 0.93 SMN1; SMN2 (0.75) SMN1; SMN2HDAC3HDAC1HDAC2HDAC10
SCHEMBL21443012 0.93 SMN1; SMN2 (0.75) SMN1; SMN2HDAC3HDAC1HDAC2HDAC10
SCHEMBL21442874 0.93 SMN1; SMN2 (0.75) SMN1; SMN2HDAC3HDAC1HDAC2HDAC10
SCHEMBL1456476 0.93 SMN1; SMN2 (0.75) SMN1; SMN2HDAC3HDAC1HDAC2HDAC10
SCHEMBL5002618 0.93 SMN1; SMN2 (0.75) SMN1; SMN2HDAC3HDAC1HDAC2HDAC10
SCHEMBL12196021 0.93 SMN1; SMN2 (0.75) SMN1; SMN2HDAC3HDAC1HDAC2HDAC10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1867572-A proteasome inhibitors and methods of use thereof CEPHALON INC (US) 2006-11-22 CN claimed
CN-1028529-C Process for preparing endophenylene oxabicycloheptyl substituted prostaglandin analogs SQUIBB & SONS INC (US) 1995-05-24 CN claimed
US-7576117-B1 Cyclic amine CCR3 antagonist TEIJIN LIMITED (JP) 2009-08-18 US disclosed
WO-2009013212-A2 DUAL MODULATORS OF 5-HT2A AND D3 RECEPTORS F. HOFFMANN-LA ROCHE AG (CH) 2009-01-29 WO disclosed
EP-1254099-A2 PROCESS FOR THE PRODUCTION OF ANHYDROUS FORMIC ACID BASF AKTIENGESELLSCHAFT (DE) 2002-11-06 EP disclosed
EP-1252128-A1 METHOD FOR PRODUCING ANHYDROUS FORMIC ACID BASF AKTIENGESELLSCHAFT (DE) 2002-10-30 EP disclosed
EP-1250306-A2 METHOD FOR CLEANING OFF-GAS FLOWS BASF AKTIENGESELLSCHAFT (DE) 2002-10-23 EP disclosed
EP-1250307-A1 UTILIZATION OF AN EXTRACTING AGENT AS ANTIFOAMING AGENT IN THE PRODUCTION OF ANHYDROUS FORMIC ACID BASF AKTIENGESELLSCHAFT (DE) 2002-10-23 EP disclosed
WO-2001055077-A2 FACILITY AND METHOD FOR THE PRODUCTION OF ANHYDROUS FORMIC ACID BASF AKTIENGESELLSCHAFT (DE) 2001-08-02 WO disclosed
WO-2001055070-A2 METHOD FOR CLEANING OFF-GAS FLOWS BASF AKTIENGESELLSCHAFT (DE) 2001-08-02 WO disclosed
WO-2001055071-A1 UTILIZATION OF AN EXTRACTING AGENT AS ANTIFOAMING AGENT IN THE PRODUCTION OF ANHYDROUS FORMIC ACID BASF AKTIENGESELLSCHAFT (DE) 2001-08-02 WO disclosed
WO-2001053244-A1 METHOD FOR PRODUCING ANHYDROUS FORMIC ACID BASF AKTIENGESELLSCHAFT (DE) 2001-07-26 WO disclosed
EP-0513285-A1 IMIDAZOL-2-YL DERIVATIVES OF SUBSTITUTED BICYCLIC COMPOUNDS AND PROCESS FOR THEIR PREPARATION. ERBA CARLO SPA (IT) 1992-11-19 EP disclosed